OUR CLINICAL STUDY
Our clinical study, The Effects of Cord Tissue Derived MSCs on the Treatment of Chronic Low Grade Inflammation, is registered with the government of the Cayman Islands (Trial HPC/CTr/003).
OUR STEM CELLS
Our cells are ethically sourced from AATB certified, US-donated, full term human umbilical cords and processed in our award-winning partner medical laboratory located in the USA, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified. The cells are tested to ISCT standards for viability to ensure they meet minimum QA requirements multiple times before treatment.
Find out if you are a candidate
Revolutionizing
Mesenchymal Stem Cell Therapy
2009
2022
We follow the highest standard, respecting safety & innovation in the delivery of culturally expanded MSCs. Our clinic in the Cayman Islands is currently enrolling patients for phase II/III clinical study utilizing culture-expanded umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs).
200+ patients enrolled worldwide
Find out if you are a candidate